We are live on ! Find out more
P3I

Progeny 3 Inc Portfolio holdings

AUM $1.87B
1-Year Est. Return 30.4%
This Fund
S&P 500
This Quarter Est. Return
+27.15%
1 Year Est. Return
+30.4%
3 Year Est. Return
+93.15%
5 Year Est. Return
+152.58%
10 Year Est. Return
+326.29%
AUM
$533M
AUM Growth
+$163M
Cap. Flow
+$88.6M
Cap. Flow %
16.62%
Top 10 Hldgs %
80.9%
Holding
27
New
4
Increased
12
Reduced
Closed
4

Sector Composition

Rank Sector Weight
1 Energy 40.74%
2 Technology 16.24%
3 Materials 10.02%
4 Financials 7.64%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGRN
26
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-11,695
Closed -$39K
SHCAU
27
DELISTED
Spindletop Health Acquisition Corp. Unit
SHCAU
-1,500,000
Closed -$15.1M

Similar funds

Progeny 3 Inc's Q1 2022 Portfolio in Review

As of Q1 2022, Progeny 3 Inc held 27 positions worth $533M, up 44% from $370M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Progeny 3 Inc deployed $88.6M of net new capital in Q1 2022, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was Spindletop Health Acquisition Corp. Class A Common Stock: 1,500,000 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 41% of assets, up from 33% a quarter earlier, followed by Technology and Materials.

On the sell side, the most notable exit was Spindletop Health Acquisition Corp. Unit, an estimated $15.1M sold.

  • Progeny 3 Inc's largest Q1 2022 buy was Spindletop Health Acquisition Corp. Class A Common Stock: 1,500,000 shares worth $14.9M.
  • Progeny 3 Inc added most to MPLX in Q1 2022, an estimated $13M increase.
  • Progeny 3 Inc fully exited Spindletop Health Acquisition Corp. Unit in Q1 2022, selling an estimated $15.1M.
  • Progeny 3 Inc's ten largest holdings make up 81% of its $533M portfolio in Q1 2022.
  • Progeny 3 Inc opened 4 new positions and closed 4 in Q1 2022.
  • Progeny 3 Inc's portfolio value rose 44% quarter-over-quarter to $533M.

Based on Progeny 3 Inc's 13F filing for Q1 2022, filed 16 May 2022.